The decision on whether to release transgenic crops in the EU is subject to irreversibility, uncertainty and flexibility. We analyse the case of herbicide-tolerant sugar beet and assess whether the EU’s 1998 de facto moratorium on transgenic crops for sugar beet was correct from a cost–benefit perspective, using a real option approach. We show that the decision was correct, providing households on average value the possible annual irreversible costs of herbicide-tolerant sugar beet at €1 or more. On the other hand, the total net private reversible benefits forgone if the de facto moratorium is not lifted are around €169 million per year.
No takes yet. Share an insight, caveat, or question.
Matty Demont (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: